Skip to main content

Advertisement

Table 1 Patient baseline characteristics and detection rate by age and gender

From: Difference analysis in prevalence of incidental pancreatic cystic lesions between computed tomography and magnetic resonance imaging

  CT MRI
Age (y) 62.26 ± 14.14 60.74 ± 13.86
Gender (M/F) 418/620 498/784
Location of PCLs
 Uncinate 12.0%(125/1038) 10.6%(136/1282)
 Head 20.2%(210/1038) 22.8%(292/1282)
 Neck 13.3%(138/1038) 13.6%(175/1282)
 Body 32.1%(333/1038) 31.9%(409/1282)
 Tail 22.4%(232/1038) 21.1%(270/1282)
Detection rate by Gender
 Male 1.54% (418/27143) 2.63%(498/18954)
 Female 2.30% (620/27067) 4.10%(784/19145)
Detection rate by Age
  ≤ 29 0.40%(24/6000) 0.58%(36/6196)
 30–39 0.83%(47/5657) 1.56%(65/4176)
 40–49 1.40%(106/7570) 2.83%(139/4917)
 50–59 1.80%(225/12500) 3.50%(292/8349)
 60–69 2.21%(314/14236) 4.49%(422/9391)
 70–79 3.46%(208/6007) 6.06%(232/3827)
  ≥ 80 5.09%(114/2240) 7.72%(96/1243)
  1. Abbreviations: CT computed tomography, MRI magnetic resonance imaging, M male, F female, PCLs pancreatic cystic lesions